Stephen Curtis - Profile and Investment Details

Investor Profile

Stephen Curtis is a Venture Capital, Private Equity Firm, Investor based in Canton, Massachusetts, United States with a diverse investment portfolio that includes companies such as CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology, CODA Biotherapeutics, Tetherex Pharmaceuticals, Motus Therapeutics, Astute Medical, Clinical Ink, iPierian, Cullinan Oncology, TriVascular, Frontier Medicines, Aktis Oncology, Entrada Therapeutics, Atopix Therapeutics, Trishula Therapeutics, Aratana Therapeutics, Harpoon Therapeutics, Umoja Biopharma, Radius Health, Oncorus, Proteon Therapeutics, Rhythm Metabolic, ElevateBio, MPM Capital, Valeritas, Werewolf Therapeutics, Repare Therapeutics, Semma Therapeutics, Nevro, Kalidex Pharmaceuticals, Chiasma, 23andMe, Selexys Pharmaceuticals Corporation, Iconic Therapeutics, Dyne Therapeutics, Blade Therapeutics, Theraclone Sciences, Vascular Pharmaceuticals, Celladon, Raze Therapeutics, BrightEdge - American Cancer Society , Conatus Pharmaceuticals, Twentyeight-Seven Therapeutics, Amphivena Therapeutics, True North Therapeutics, SiO2 Medical Products, Cerecor, NextPoint Therapeutics, Inc., TCR2, arGEN-X, Triplet Therapeutics, NeoVista, Tizona Therapeutics, Sideris Pharmaceuticals, ReCode Therapeutics, BioIntervene, Rhythm Pharmaceuticals, ITeos Therapeutics, Orna Therapeutics, IOmx Therapeutics, Syndax Pharmaceuticals. Over time, Stephen Curtis has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Stephen Curtis is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Drug Discovery, Genetics, Wellness, Life Science, Emerging Markets, Medical Technologies, Information Technology (IT), Finance, Biotechnology, Medical Devices, Genomics, UK Startups, Developer Tools, Medical, B2B, Therapeutics, Health Tech, Emergency Medicine, Pharmaceuticals, Healthcare Technology, Oncology may find it worthwhile to explore potential connections with Stephen Curtis, as their portfolio suggests a familiarity and interest in this area.

Understanding Stephen Curtis’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.